Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Inj delandistrogene mox rokl (OTHER 0714) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 11, 2026 , from http://ppman.hank.ai/transparency/procedure/0714/by-state?code_type=OTHER
“Inj delandistrogene mox rokl (OTHER 0714) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/0714/by-state?code_type=OTHER. Accessed
October 11, 2026 .
“Inj delandistrogene mox rokl (OTHER 0714) by State,” HANK Price Transparency ,
accessed October 11, 2026 ,
http://ppman.hank.ai/transparency/procedure/0714/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
0714 — Inj Delandistrogene Mox Rokl
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$3,316,463
National median
$3,316,463 – $3,417,326
IQR (p25 – p75)
16
hospitals filing
7
states
Walking in without insurance?
Cash / self-pay price
Cash median
$2,653,170
vs. negotiated
-20.0%
Hospitals reporting
7
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 0714 (OTHER), with interquartile range
State Median p25 p75
CA $4,414,760 $4,140,816 $4,972,276
PA $3,415,956 $3,316,463 $3,482,286
MI $3,316,463 $1,734,510 $3,316,463
NY $3,316,463 $3,316,463 $3,415,956
HI $3,288,564 $3,255,346 $3,479,566
NE $3,211,266 $3,185,256 $3,237,275
KY $2,967,637 $2,967,637 $2,967,637